Literature DB >> 29361464

Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease.

Karthickeyan Chella Krishnan1, Zeyneb Kurt2, Rio Barrere-Cain2, Simon Sabir3, Aditi Das3, Raquel Floyd4, Laurent Vergnes5, Yuqi Zhao2, Nam Che1, Sarada Charugundla1, Hannah Qi1, Zhiqiang Zhou1, Yonghong Meng1, Calvin Pan1, Marcus M Seldin1, Frode Norheim1, Simon Hui1, Karen Reue5, Aldons J Lusis6, Xia Yang7.   

Abstract

The etiology of non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease, is poorly understood. To understand the causal mechanisms underlying NAFLD, we conducted a multi-omics, multi-tissue integrative study using the Hybrid Mouse Diversity Panel, consisting of ∼100 strains of mice with various degrees of NAFLD. We identified both tissue-specific biological processes and processes that were shared between adipose and liver tissues. We then used gene network modeling to predict candidate regulatory genes of these NAFLD processes, including Fasn, Thrsp, Pklr, and Chchd6. In vivo knockdown experiments of the candidate genes improved both steatosis and insulin resistance. Further in vitro testing demonstrated that downregulation of both Pklr and Chchd6 lowered mitochondrial respiration and led to a shift toward glycolytic metabolism, thus highlighting mitochondria dysfunction as a key mechanistic driver of NAFLD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  glycolysis; integrative genomics; key driver genes; mitochondrial dysfunction; mouse diversity panel; multi-omics integration; network modeling; non-alcoholic fatty liver disease; oxidative phosphorylation; systems biology

Mesh:

Substances:

Year:  2018        PMID: 29361464      PMCID: PMC5799036          DOI: 10.1016/j.cels.2017.12.006

Source DB:  PubMed          Journal:  Cell Syst        ISSN: 2405-4712            Impact factor:   10.304


  61 in total

1.  A position statement on NAFLD/NASH based on the EASL 2009 special conference.

Authors:  Vlad Ratziu; Stefano Bellentani; Helena Cortez-Pinto; Chris Day; Giulio Marchesini
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

2.  Systems proteomics of liver mitochondria function.

Authors:  Evan G Williams; Yibo Wu; Pooja Jha; Sébastien Dubuis; Peter Blattmann; Carmen A Argmann; Sander M Houten; Tiffany Amariuta; Witold Wolski; Nicola Zamboni; Ruedi Aebersold; Johan Auwerx
Journal:  Science       Date:  2016-06-10       Impact factor: 47.728

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.

Authors:  Takuya Kitamoto; Aya Kitamoto; Masato Yoneda; Hideyuki Hyogo; Hidenori Ochi; Takahiro Nakamura; Hajime Teranishi; Seiho Mizusawa; Takato Ueno; Kazuaki Chayama; Atsushi Nakajima; Kazuwa Nakao; Akihiro Sekine; Kikuko Hotta
Journal:  Hum Genet       Date:  2013-03-28       Impact factor: 4.132

6.  Identification of a physiologically relevant endogenous ligand for PPARalpha in liver.

Authors:  Manu V Chakravarthy; Irfan J Lodhi; Li Yin; Raghu R V Malapaka; H Eric Xu; John Turk; Clay F Semenkovich
Journal:  Cell       Date:  2009-07-30       Impact factor: 41.582

7.  DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes.

Authors:  Janet Piñero; Núria Queralt-Rosinach; Àlex Bravo; Jordi Deu-Pons; Anna Bauer-Mehren; Martin Baron; Ferran Sanz; Laura I Furlong
Journal:  Database (Oxford)       Date:  2015-04-15       Impact factor: 3.451

8.  Mergeomics: multidimensional data integration to identify pathogenic perturbations to biological systems.

Authors:  Le Shu; Yuqi Zhao; Zeyneb Kurt; Sean Geoffrey Byars; Taru Tukiainen; Johannes Kettunen; Luz D Orozco; Matteo Pellegrini; Aldons J Lusis; Samuli Ripatti; Bin Zhang; Michael Inouye; Ville-Petteri Mäkinen; Xia Yang
Journal:  BMC Genomics       Date:  2016-11-04       Impact factor: 3.969

9.  Shared genetic regulatory networks for cardiovascular disease and type 2 diabetes in multiple populations of diverse ethnicities in the United States.

Authors:  Le Shu; Kei Hang K Chan; Guanglin Zhang; Tianxiao Huan; Zeyneb Kurt; Yuqi Zhao; Veronica Codoni; David-Alexandre Trégouët; Jun Yang; James G Wilson; Xi Luo; Daniel Levy; Aldons J Lusis; Simin Liu; Xia Yang
Journal:  PLoS Genet       Date:  2017-09-28       Impact factor: 5.917

Review 10.  Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum.

Authors:  Timothy Hardy; Fiona Oakley; Quentin M Anstee; Christopher P Day
Journal:  Annu Rev Pathol       Date:  2016-03-03       Impact factor: 23.472

View more
  45 in total

1.  Prenatal Bisphenol A Exposure in Mice Induces Multitissue Multiomics Disruptions Linking to Cardiometabolic Disorders.

Authors:  Le Shu; Qingying Meng; Graciel Diamante; Brandon Tsai; Yen-Wei Chen; Andrew Mikhail; Helen Luk; Beate Ritz; Patrick Allard; Xia Yang
Journal:  Endocrinology       Date:  2019-02-01       Impact factor: 4.736

2.  Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export.

Authors:  Fawzi Alogaili; Sivaprakasam Chinnarasu; Anja Jaeschke; Evangelia G Kranias; David Y Hui
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

3.  Widespread Dysregulation of Long Noncoding Genes Associated With Fatty Acid Metabolism, Cell Division, and Immune Response Gene Networks in Xenobiotic-exposed Rat Liver.

Authors:  Kritika Karri; David J Waxman
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

Review 4.  Mouse Systems Genetics as a Prelude to Precision Medicine.

Authors:  Hao Li; Johan Auwerx
Journal:  Trends Genet       Date:  2020-02-06       Impact factor: 11.639

Review 5.  Multitissue Multiomics Systems Biology to Dissect Complex Diseases.

Authors:  Xia Yang
Journal:  Trends Mol Med       Date:  2020-05-18       Impact factor: 11.951

Review 6.  Integrative omics approaches provide biological and clinical insights: examples from mitochondrial diseases.

Authors:  Sofia Khan; Gulayse Ince-Dunn; Anu Suomalainen; Laura L Elo
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

7.  Differential metabolic and multi-tissue transcriptomic responses to fructose consumption among genetically diverse mice.

Authors:  Guanglin Zhang; Hyae Ran Byun; Zhe Ying; Montgomery Blencowe; Yuqi Zhao; Jason Hong; Le Shu; Karthick Chella Krishnan; Fernando Gomez-Pinilla; Xia Yang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-10-25       Impact factor: 5.187

Review 8.  Systems genetics applications in metabolism research.

Authors:  Marcus Seldin; Xia Yang; Aldons J Lusis
Journal:  Nat Metab       Date:  2019-10-21

Review 9.  Systems Genetics for Mechanistic Discovery in Heart Diseases.

Authors:  Christoph D Rau; Aldons J Lusis; Yibin Wang
Journal:  Circ Res       Date:  2020-06-04       Impact factor: 17.367

10.  Multi-Tissue Multi-Omics Nutrigenomics Indicates Context-Specific Effects of Docosahexaenoic Acid on Rat Brain.

Authors:  Guanglin Zhang; Qingying Meng; Montgomery Blencowe; Rahul Agrawal; Fernando Gomez-Pinilla; Xia Yang
Journal:  Mol Nutr Food Res       Date:  2020-10-15       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.